0 items USD 0.00Search
- Did you mean
- antibody-oligonucleotide conjugate
Your search for "Antibody-Oligonucleotide Conjugates" gave back 9 results.
This report provides you with a landscape description and analysis of degrader-antibody conjugate (DAC) stakeholders, platform technologies,...
颁补迟补濒辞驳:听
La Merie Publishing
September 2024
Price: USD 2,300.00
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
颁补迟补濒辞驳:听
La Merie Publishing
November 2022
Price: USD 2,500.00
鈥淣on-alcoholic steatohepataitis (NASH) Pipeline Analysis鈥� gives comprehensive insights on the various drugs being developed for the treatment of NASH...
IQ4I
October 2019
Price: USD 3,600.00
鈥淟utetium-177 Global 麻豆原创 Analysis鈥� gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of GEP-NET,...
IQ4I
February 2020
Price: USD 3,600.00
The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic...
颁补迟补濒辞驳:听
La Merie Publishing
March 2014
Price: USD 1,112.00
鈥淣onalcoholic steatohepatitis (NASH) Pipeline Analysis鈥� gives comprehensive insight on the various drugs being developed for the treatment of NASH...
颁补迟补濒辞驳:听
IQ4I
July 2015
Price: USD 3,600.00
The Competitive Intelligence report about Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates provides a competitor analysis in the...
颁补迟补濒辞驳:听
La Merie Publishing
January 2015
Price: USD 249.00
The Competitive Intelligence report about Alpha Synuclein and LRRK2 Inhibitors - Novel Drug Candidates for Parkinson鈥檚 Disease provides a competitor...
颁补迟补濒辞驳:听
La Merie Publishing
January 2015
Price: USD 249.00
Retinoic acid-related orphan nuclear receptor gamma (RORgamma) is a hot, but 鈥瀌ifficult-to-drug鈥� target. More than 30 companies are active in drug...
颁补迟补濒辞驳:听
La Merie Publishing
February 2016
Price: USD 1,050.00
听
